Human papillomavirus DNA and p53 status in penile carcinomas

International Journal of Cancer

Volumn 76, Issue 6, 1998, Pages 779-783

  Levi, José E ^a,b   Rahal, Paula ^a   Sakkis, Álvoro S ^b   Villa, Luisa L ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; HUMAN; HUMAN TISSUE; MALE; PENIS CARCINOMA; PRIORITY JOURNAL; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS GENE; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; DNA, VIRAL; GENES, P53; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PENILE NEOPLASMS; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032503494     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980610)76:6<779::AID-IJC1>3.0.CO;2-V     Document Type: Article

References (31)

1. BAAY, M.F.D., QUINT, W.G.V., KOUDSTAAL, J., HOLLEMA, H., DUK, J.M., BURGER, M.P.M., STOLZ, E. and HERBRINK, P., Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J. clin. Microbiol., 34, 745-747 (1996).
2. BORRESEN, A.L., HELLAND, A., NESLAND, J., HOLM, R., TROPE, C. and KAERN, J., Papillomaviruses, p53 and cervical cancer. Lancet, 339, 1350 (1992).
3. BUTZ, K., SHAHABEDDIN, L., GEISEN, C., SPITKOVSKY, D., ULLMAN, A. and HOPPE-SEYLER, F., Functional p53 protein in human papillomavirus-positive cancer cells. Oncogene, 10, 927-936 (1995).
4. CHAN, K.W., LAM, K.Y., CHAN, A.C.L., LAU, P. and SRIVASTVA, G., Prevalence of human papillomavirus types 16 and 18 in penile carcinoma: a study of 41 cases using PCR. J. clin. Pathol., 47, 823-826 (1994).
5. CHELLAPPAN, S., KRAUS. V.B., KROGER, B., MUNGER, K., HOWLEY, P.M., PHELPS, W.C. AND NEVINS J.R., Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. nat. Acad. Sci. (Wash.), 89,4549-4553 (1992).
6. CROOK, T., WREDE, D., TIDY, J.A., MASON, W.P. and EVANS, D.J. Clonal p53 mutation in primary cervical cancer: association with human papillomavirus negative tumours. Lancet, 339, 1070-1073 (1992).
7. FUJITA, M., INOUE, M., TANIZAWA, O., IWAMOTO, S. and ENOMOTO, T., Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res., 52,5323-5328 (1992).
8. GRAHAM, S., PRIORE, R. and GRAHAM, M., Genital cancer in wives of penile cancer patients. Cancer, 44, 1870-1874 (1979).
9. GREGOIRE, L., CUBILLA, A.L., REUTER, V.E., HAAS, G.P. and LANCASTER, W.D., Preferential association of human pupillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma. J. Natl. Cancer lnst., 87, 1705-1709 (1995).
10. HOLLAND, A., HOLM, R., KRISTENSEN, G., KAERN, J., KARLSEN TROPE, C., NESLAND, J.M. and BORRESEN A.-L., Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas. J. Pathol., 171, 105-114 (1993).
11. HIGGINS, G.D., UZELIN, D.M., PHILLIPS, G.E., VILLA, L.L. and BURREL, C.J., Differing prevalence of human papillomavirus RNA in penile dysplasias and carcinomas may reflect differing etiologies. Am. J. clin. Pathol., 97, 272-278 (1992).
12. HOLLSTEIN M., SHOMER B., GREENBLATT M., SOUSSI T., HOVIG E., MONTE-SANO R. and HARRIS C.C., Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucl. Acids Res., 24, 141-146 (1996).
13. HOLLSTEIN, M., SIDRANSKV, D., VOGELSTEIN, B. and HARRIS. C.C., p53 mutations in human cancers. Science. 253, 49-54 (1991).
14. IARC, Monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses. Vol. 64, IARC, Lyon. (1995)
15. LAM, K.Y., CHAN, A.C.L., CHAN, K.W., LEUNG, M.L. and SRIVASTAVA, G., Expression of p53 and its relationship with human papillomavirus in penile carcinomas. Eur J. surg. Oncol., 21, 613-616 (1995).
16. LEVI, J.E., DELCELO, R., ALBERTI, V.N., TORKINI, H. and VILLA, L.L., Human papillomavirus DNA in respiratory papillomatosis detected by in situ hybridization and the polymerase chain reaction. Amer. J. Pathol., 6, 1179-1184 (1989).
17. LUTZKER S.G. and LEVINE A.J., A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation. Nature (Med.), 2, 804-810 (1996).
18. MADEN, C., SHERMAN, K.J., BECKMANN, A.M., HISLOP, T.G., TEH, C.Z., ASHLEY, R.L. and DALING, J.R., History of circumcision, medical conditions and sexual activity and risk of penile cancer, J. nat. Cancer Inst., 85, 19-24 (1993).
19. MANOS, M.M., TING, Y., WRIGHT, D.K., LEWIS, A.J., BROKER, T.R. and WOLINSKY, S.M., The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells, 7, 209-214 (1989).
20. McCANCE, D.J., KALACHE, A., ASHDOWN, K., ANDRADL, L., MENEZES, F., SMITH, P. and DOLL, R., Human papillomavirus types 16 and 18 in carcinomas of the penis from Brazil. Int. J. Cancer, 37, 55-59 (1986).
21. PAQUETTE, R.L., LEE. Y.Y., WILCZYNSKI, S.P., KARMAKAR, A., KIZAKI, M., MILLIER, C.W. and KOEFFLER H.P., Mutations of p53 and human papillomavirus infection in cervical carcinoma. Cancer 72, 1272-1280 (1993).
22. PARK, D.J., WILCZYNSKI, S.P., PAQUETTE, R.L., MILLER, C.W. and KOEFFER, H.P., p53 mutations in HPV-negative cervical carcinoma. Oncogene, 9, 205-210 (1994).
23. PARKIN, D.M., MUIR, C.S., WHELAN, S.L., GAO, Y.T., SERLAY, J. and POWLLL, J. (eds.), Cancer incidence in five continents. IARC Scientific Publications 120, vol, 4. IARC, Cancer, Lyon (1992).
24. SAIKI, R.K., BUGAWAN, T.L., HORN, G.T., MULLIS, K.B. and ERLICH, H.A. Analysis of enzymatically amplified beta-globin and HLA-DQalfa DNA with allele-speciric oligonueleotide probes. Nature (Lond.), 324, 163-166 (1986).
25. SARKAR, F.H., MILES, B.J., PLIETH, D.H. and CRISSMAN, J.D. Detection of human papillomavirus in squamous neoplasm of the penis. J. Urol., 147, 389-392 (1992).
26. SUZUKI, H., SATO, N., KODAMA, T., OKANO, T., ISAKA, S., SHIRASAWA, H., SIMIZU, B. and SHIMAZAKI, J., Detection of human papillomavirus DNA and state of p53 gene in Japanese penile cancer. Jpn. J. clin. Oncol., 24, 1-6 (1994).
27. TERVAHAUTA, A.L., SYRJANEN, S.M., MANTYJARVI, R. and SYRJANEN, KJ., Detection of p53 protein and Ki-67 proliferation antigen in human papillomavirus (HPV) positive and HPV-negative cervical lesions by immunohistochemical double-staining. Cytopathology, 5, 282-293 (1994).
28. TORNESELLO, M.L., BUONAGURO, F.M., BETH-GIRALDO, E., KYALWAZI, S.K., and GIRALDO, G., Human papillomavirus (HPV) DNA in penile carcinomas and in two cell lines from high-incidence areas for genital cancers in Africa. Int. J. Cancer. 51, 587-592 (1992).
29. VILLA, L.L. and LOPES A., Human papillomavirus DNA sequences in penile carcinomas in Brazil. Int. J. Cancer. 37, 853-655 (1986).
30. VILLA, L.L., RAHAL, P. and FRANCO, E.L., Molecular variant analysis as a tool in natural history studies of human papillomavirus infection and cervical neoplasia. In: E.L. Franco and J. Monsonego (eds.), New developments in cervical cancer screening and prevention, pp. 379-385, Blackwell, London (1997).
31. WIENKR, J.S., EFFERT, P.J., HUMPHRY, P.A., YU, L., LIU, E.T. and WALTHER, P.J., Prevalence of human papillomavirus types 16 and 18 in squamous-cell carcinoma of the penis: a retrospective analysis of primary and metastatic lesions by differential polymerase chain reaction. Int. J. Cancer. 50, 694-701 (1992).